alpha-L-Araf-(1->2)-[beta-D-Glcp-(1->3)]-alpha-L-Arap

Term ID

CHEBI:148831

Synonyms

(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S)-3-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2,5-dihydroxyoxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
alpha-L-arabino-pentofuranosyl-(1->2)-[beta-D-gluco-hexopyranosyl-(1->3)]-alpha-L-arabino-pentopyranose
alpha-L-arabinofuranosyl-(1->2)-[beta-D-glucopyranosyl-(1->3)]-alpha-L-arabinopyranose
Araf(a1-2)[Glc(b1-3)]a-Ara

Definition

A trisaccharide consisting of α-L-arabinofuranose and α-L-arabinopyranose residues joined in sequence by a (1→2) glycosidic bond, and in which a β-D-glucopyranose residue has been attached to the arabinopyranose residue by a (1→3) glycosidic bond.

References

glytoucan:G27025WD

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-L-Araf-(1->2)-[beta-D-Glcp-(1->3)]-alpha-L-Arap

Phenotype where environments contain alpha-L-Araf-(1->2)-[beta-D-Glcp-(1->3)]-alpha-L-Arap

Phenotype modified by environments containing alpha-L-Araf-(1->2)-[beta-D-Glcp-(1->3)]-alpha-L-Arap

Phenotype affecting alpha-L-Araf-(1->2)-[beta-D-Glcp-(1->3)]-alpha-L-Arap

Human Disease Model